Agenda Clinical Hematology & Oncology 2024
Friday, February 2, 2024
11 a.m.
Registration Opens
11:30 a.m.
Pre-Conference Symposium
Non-CME Activity Hosted by Agios Pharmaceuticals
11:30 a.m.
Pre-Conference Symposium
Non-CME Activity Hosted by EMD Serono
12:30 p.m.
Break & View Exhibits
Non-Malignant Hematology
12:50 p.m.
Welcome & Educational Overview
1 p.m.
Thrombosis: 2024 Update
1:30 p.m.
Management of Hematologic Conditions in Athletes
2 p.m.
Management of Autoimmune, Viral and Surgical-associated Anti-PF4 Disorders
2:30 p.m.
Panel Discussion/Q&A
3 p.m.
Break & View Exhibits
3:15 p.m.
Hemolytic Anemias – Autoimmune, Membrane and Enzyme Defects
3:45 p.m.
Heavy Menstrual Bleeding: Workup for Bleeding Disorder and Management
4:15 p.m.
Management of Simultaneous Venous and Arterial Thromboembolic Disease
4:45 p.m.
Panel Discussion/Q&A
Concurrent Breakout Sessions: Clinical Cases
5:15 p.m.
Breakout #1: Interesting Cases in Thrombosis
Breakout #2: Interesting Cases in Platelet Disorders
Breakout #3: Interesting Cases in Bleeding
Breakout #4: Interesting Cases in Plasma Cell Dyscrasias
6:15 p.m.
Adjourn
6:30 p.m.
Welcome & Networking Reception
Saturday, February 3, 2024
6:45 a.m.
Breakfast Symposium
Non-CME Activity Hosted by Rigel Pharmaceuticals
6:45 a.m.
Breakfast Symposium
Non-CME Activity Hosted by Takeda Oncology
7 a.m.
Breakfast & View Exhibits
Malignant Hematology
7:55 a.m.
Welcome & Announcements
8 a.m.
Myeloproliferative Neoplasms: 2024 Update
8:30 a.m.
Smoldering Multiple Myeloma
9 a.m.
BTK Refractory CLL
9:30 a.m.
Panel Discussion/Q&A
10 a.m.
Break & View Exhibits
10:30 a.m.
Detangling New Approaches to Hairy Cell Leukemia – A Comb or a Brush?
11 a.m.
Advances in Frontline Treatment of FLT3-mutated AML
11:30 a.m.
Management of MDS/AML in the Geriatric Patient
Noon
Panel Discussion/Q&A
12:30 p.m.
Lunch
12:30 p.m.
Lunch Symposium
Non-CME Activity Hosted by Pfizer
Malignant Hematology – Non-Hodgkin Lymphomas
1:30 p.m.
Frontline Treatment of DLBCL
2 p.m.
Updates in the Treatment of Relapsed DLBCL
2:30 p.m.
Management of Indolent NHL
3 p.m.
Panel Discussion/Q&A
3:30 p.m.
Break & View Exhibits
Concurrent Breakout Sessions: Clinical Cases
4 p.m.
Breakout #1: Interesting Cases in Thrombosis
Breakout #2: Interesting Cases in Platelet Disorders
Breakout #3: Interesting Cases in Bleeding
Breakout #4: Interesting Cases in Plasma Cell Dyscrasias
5 p.m.
Adjourn
5:30 p.m.
Dinner Symposium
Non-CME Activity Hosted by AstraZeneca
Sunday, February 4, 2024
6:45 a.m.
Breakfast Symposium
Non-CME Activity Hosted by Seagen
7 a.m.
Breakfast & View Exhibits
Breast Cancer, Neuro-Oncology and Melanoma
7:50 a.m.
Welcome & Announcements
8 a.m.
Breast Cancer in Pregnancy
8:30 a.m.
Anthracyclines in Early Breast Cancer – Do They Still Have a Role?
9 a.m.
CDK4/6 Inhibitor Therapy in Early-stage HR+/HER2- Breast Cancer
9:30 a.m.
Panel Discussion/Q&A
10 a.m.
Break & View Exhibits
10:30 a.m.
Neuro-Oncology: 2024 Update
11 a.m.
Combination Immunotherapy in Melanoma
11:30 a.m.
Sequencing Therapies in Metastatic Urothelial Carcinoma
Noon
Panel Discussion/Q&A
12:30 p.m.
Lunch
12:30 p.m.
Lunch Symposium
Non-CME Activity Hosted by Exelixis
12:30 p.m.
Lunch Symposium
Non-CME Activity Hosted by Pfizer
GI and GYN Cancers
1:30 p.m.
Artificial Intelligence in Oncology
2 p.m.
Integrating Immunotherapy into the Treatment of Cervical and Endometrial Cancers
2:30 p.m.
New Approaches to Recurrent or Metastatic Ovarian Cancer
3 p.m.
Panel Discussion/Q&A
3:30 p.m.
Break & View Exhibits
3:45 p.m.
Optimal Treatment Approaches for Localized Rectal Adenocarcinoma
4:15 p.m.
Targeted Therapy Approaches for Upper GI Cancer
4:45 p.m.
Updates on Immune Therapy Approaches for pMMR Cancers
5:15 p.m.
Panel Discussion/Q&A
5:45 p.m.
Final Adjournment
Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.